Joshua F. Baker

9.5k total citations
219 papers, 5.1k citations indexed

About

Joshua F. Baker is a scholar working on Rheumatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Joshua F. Baker has authored 219 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Rheumatology, 36 papers in Pathology and Forensic Medicine and 35 papers in Epidemiology. Recurrent topics in Joshua F. Baker's work include Rheumatoid Arthritis Research and Therapies (112 papers), Systemic Lupus Erythematosus Research (43 papers) and Autoimmune and Inflammatory Disorders Research (27 papers). Joshua F. Baker is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (112 papers), Systemic Lupus Erythematosus Research (43 papers) and Autoimmune and Inflammatory Disorders Research (27 papers). Joshua F. Baker collaborates with scholars based in United States, Denmark and United Kingdom. Joshua F. Baker's co-authors include H. Ralph Schumacher, Michael George, Eswar Krishnan, Mary B. Leonard, Ted R. Mikuls, Daniel E. Fürst, Bryant R. England, Lan S. Chen, Jin Long and Daniel G. Baker and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Joshua F. Baker

206 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joshua F. Baker United States	39	2.2k	908	749	743	730	219	5.1k
Mimi Kim United States	48	2.8k 1.3×	734 0.8×	374 0.5×	558 0.8×	1.1k 1.4×	195	7.7k
J. Antonio Aviña‐Zubieta Canada	37	3.1k 1.4×	372 0.4×	312 0.4×	634 0.9×	990 1.4×	125	5.9k
Matthew J. Grainge United Kingdom	51	2.1k 1.0×	1.7k 1.9×	605 0.8×	1.4k 1.8×	1.2k 1.6×	152	11.2k
Elizabeth W. Karlson United States	48	4.7k 2.2×	1.6k 1.8×	376 0.5×	1.5k 2.1×	1.0k 1.4×	110	8.8k
Jean‐Pierre Daurès France	43	914 0.4×	230 0.3×	1.0k 1.4×	547 0.7×	913 1.3×	168	6.8k
Eswar Krishnan United States	50	2.6k 1.2×	2.9k 3.2×	292 0.4×	1.5k 2.0×	1.0k 1.4×	113	7.5k
Mary A. De Vera Canada	35	1.2k 0.6×	1.1k 1.2×	139 0.2×	525 0.7×	423 0.6×	160	3.9k
James Galloway United Kingdom	37	2.7k 1.3×	150 0.2×	280 0.4×	571 0.8×	802 1.1×	278	5.5k
Rubén Burgos‐Vargas Mexico	40	5.4k 2.5×	603 0.7×	350 0.5×	588 0.8×	426 0.6×	186	10.2k
Grant W. Cannon United States	41	3.4k 1.6×	126 0.1×	501 0.7×	679 0.9×	568 0.8×	200	6.2k

Countries citing papers authored by Joshua F. Baker

Since Specialization

Citations

This map shows the geographic impact of Joshua F. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua F. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua F. Baker more than expected).

Fields of papers citing papers by Joshua F. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua F. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua F. Baker. The network helps show where Joshua F. Baker may publish in the future.

Co-authorship network of co-authors of Joshua F. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua F. Baker. A scholar is included among the top collaborators of Joshua F. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua F. Baker. Joshua F. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

England, Bryant R., Joshua F. Baker, Michael George, et al.. (2025). Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study. The Lancet Rheumatology. 7(3). e166–e177. 4 indexed citations

Weinstein, Erica J, Dena M. Carbonari, Craig Newcomb, et al.. (2025). Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines. Open Forum Infectious Diseases. 12(5). ofaf102–ofaf102.

Wichman, Christopher, Jianghu Dong, Punyasha Roul, et al.. (2025). Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study. Seminars in Arthritis and Rheumatism. 73. 152735–152735. 3 indexed citations

Re, Vincent Lo, Dena M. Carbonari, Craig Newcomb, et al.. (2025). Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy. Open Forum Infectious Diseases. 12(9). ofaf571–ofaf571.

Mikuls, Ted R., Joshua F. Baker, Grant W. Cannon, et al.. (2024). The Veterans Affairs Rheumatoid Arthritis Registry: A unique population in rheumatoid arthritis research. Seminars in Arthritis and Rheumatism. 70. 152580–152580.

Baker, Joshua F., Ted R. Mikuls, Geoffrey M. Thiele, et al.. (2024). Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis. Arthritis & Rheumatology. 77(3). 263–271. 2 indexed citations

Scanzello, Carla R., Karen A. Hasty, Christine B. Chung, et al.. (2024). Teaming up to overcome challenges toward translation of new therapeutics for osteoarthritis. Journal of Orthopaedic Research®. 42(12). 2659–2672. 2 indexed citations

Roul, Punyasha, Yangyuna Yang, Tate Johnson, et al.. (2023). Multimorbidity Patterns and Rheumatoid Arthritis Disease Outcomes: Findings From a Multicenter, Prospective Cohort. Arthritis Care & Research. 77(3). 337–348. 7 indexed citations

Roul, Punyasha, Yangyuna Yang, Grant W. Cannon, et al.. (2023). Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes. Arthritis Care & Research. 75(10). 2199–2206. 3 indexed citations

10.

Raynor, William, et al.. (2023). 18F-FDG and 18F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis. Diagnostics. 13(13). 2149–2149. 2 indexed citations

11.

England, Bryant R., Punyasha Roul, Yangyuna Yang, et al.. (2023). Extracting forced vital capacity from the electronic health record through natural language processing in rheumatoid arthritis‐associated interstitial lung disease. Pharmacoepidemiology and Drug Safety. 33(1). e5744–e5744. 9 indexed citations

12.

Pedro, Sofia, Kaleb Michaud, Gülşen Özen, et al.. (2023). Physical Activity Habits Among Older Adults Living With Rheumatic Disease. The Journal of Rheumatology. 50(6). 835–841. 7 indexed citations

13.

Singh, Namrata, Laura S. Gold, Jiha Lee, et al.. (2023). Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted‐Synthetic Disease‐Modifying Antirheumatic Drugs. Arthritis Care & Research. 76(5). 627–635. 6 indexed citations

14.

Zemel, Babette S., et al.. (2020). Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning. The Journal of Rheumatology. 48(4). 504–512. 11 indexed citations

15.

England, Bryant R., Punyasha Roul, Tina Mahajan, et al.. (2019). Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis. Arthritis Care & Research. 72(10). 1392–1403. 29 indexed citations

16.

Baker, Joshua F., Mikkel Østergaard, Paul Emery, Daniel G. Baker, & Philip G. Conaghan. (2017). Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 35(4). 607–613. 10 indexed citations

17.

Baker, Joshua F., Jon T. Giles, David R. Weber, et al.. (2017). Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis. Lara D. Veeken. 56(6). 981–988. 27 indexed citations

18.

Baker, Joshua F., Mikkel Østergaard, Paul Emery, et al.. (2013). Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial. Annals of the Rheumatic Diseases. 73(11). 1968–1974. 57 indexed citations

19.

Reese, Peter P., Anne Rentoumis Cappola, Justine Shults, et al.. (2013). Physical Performance and Frailty in Chronic Kidney Disease. American Journal of Nephrology. 38(4). 307–315. 139 indexed citations

20.

Baker, Joshua F., Nehal N. Mehta, Daniel G. Baker, et al.. (2012). Vitamin D, Metabolic Dyslipidemia, and Metabolic Syndrome in Rheumatoid Arthritis. The American Journal of Medicine. 125(10). 1036.e9–1036.e15. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact